These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8805647)

  • 1. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.
    Smith KD; Mace BE; Valenzuela A; Vigna JL; McCutcheon JA; Barbosa JA; Huczko E; Engelhard VH; Lutz CT
    J Immunol; 1996 Sep; 157(6):2470-8. PubMed ID: 8805647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
    Hill A; Worth A; Elliott T; Rowland-Jones S; Brooks J; Rickinson A; McMichael A
    Eur J Immunol; 1995 Jan; 25(1):18-24. PubMed ID: 7531143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles.
    Noun G; Reboul M; Abastado JP; Jaulin C; Kourilsky P; Pla M
    J Immunol; 1996 Sep; 157(6):2455-61. PubMed ID: 8805645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-induced rescue of serologic epitopes on class I MHC molecules.
    Solheim JC; Carreno BM; Myers NB; Lee DR; Hansen TH
    J Immunol; 1995 Feb; 154(3):1188-97. PubMed ID: 7529793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
    Lu J; Celis E
    Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
    Parham P
    J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
    Smith KD; Lutz CT
    J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
    Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B7 beta-pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses.
    Freese A; Zavazava N
    Blood; 2002 May; 99(9):3286-92. PubMed ID: 11964295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.
    Smith KD; Huczko E; Engelhard VH; Li YY; Lutz CT
    Transplantation; 1997 Jul; 64(2):351-9. PubMed ID: 9256200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
    Ferrante A; Gorski J
    J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.